Before we head out for the weekend, we want to highlight a recent op-ed by BIO Board Member Richard Pops, Chairman and CEO of Alkermes, on how COVID-19 has created an opportunity to modernize health care, and specifically mental health care, thanks to telehealth.
What he says: “Our industry has an opportunity—an obligation really—to harness and improve upon the efforts made over the last few months to formalize a new operating model utilizing all of the clinical, digital, and pharmacological tools at our disposal to raise the standard of care for people well into the future.”
Specifically: “True patient-centered care takes a comprehensive/holistic approach, including consideration of the appropriate medicine for the patient and accounting for the psychological, environmental, and behavioral factors that affect outcomes. This is where telemedicine, specifically telepsychiatry, can play a role.”
And while there are challenges, telemedicine and “telepsychiatry can open a world of possibilities for patients,” he continues.
Read the whole thing at Life Science Leader.
More Health Care News:
Reuters: Gilead's remdesivir set to become Europe's first COVID-19 therapy
“The European Medicines Agency (EMA) said on Thursday its human medicines committee (CHMP) recommended conditionally approving the drug for adults and adolescents from 12 years of age who are also suffering from pneumonia and require oxygen support.”